Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| biote Corp.BTMD · Entity 7156 | General Counsel | May 01, 2026 | May 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
biote Corp.
Report date May 01, 2026 · Filed May 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.19 · Expires 2036-04-30 | Direct | 88,800 |
Reported balance
After 2026-05-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 88,800 · Balance 88,800 F1: One-half (1/2) of the shares subject to the option shall vest on April 27, 2028, and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-half (1/2) of the shares subject to the option shall vest on April 27, 2028, and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 4, 2026 20:28 UTC | biote Corp. BTMD · Entity 7156 | GrantEmployee Stock Option (Right to Buy) · Derivative | 88,800 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0002125693-26-000005 · form4-05042026_080503.xml · derivative · entry 1 Monico Daniel Michael · CIK 0002125693 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,800 Underlying: Class A Common Stock · 88,800 shares Expires 2036-04-30 F1 · derivative.exercise_date: One-half (1/2) of the shares subject to the option shall vest on April 27, 2028, and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.